Amrein, P. C., Attar, E. C., Takvorian, T., Hochberg, E. P., Ballen, K. K., Leahy, K. M., . . . Brown, J. R. (2011). Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
Citação norma ChicagoAmrein, Philip C., et al. Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia. 2011.
MLA引文Amrein, Philip C., et al. Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia. 2011.
警告：這些引文格式不一定是100％准確.